[Biological and pharmacological properties of Clostridium perfringens alpha toxin].
Fujii
Y
Y
D000818:Animals; D001011:Aorta / Q000187:drug effects; D001427:Bacterial Toxins / Q000302:isolation & purification / Q000494:pharmacology*; D001794:Blood Pressure / Q000187:drug effects; D003016:Clostridium perfringens / Q000737:chemistry*; D004562:Electrocardiography / Q000187:drug effects; D006339:Heart Rate / Q000187:drug effects; D066298:In Vitro Techniques; D008297:Male; D009119:Muscle Contraction / Q000187:drug effects; D009131:Muscle, Smooth, Vascular / Q000187:drug effects; D051381:Rats; D012039:Regional Blood Flow / Q000187:drug effects; D012867:Skin / Q000098:blood supply; D014649:Vas Deferens / Q000187:drug effects; D014661:Vasoconstriction / Q000187:drug effects
D001427:Bacterial Toxins